Commercially available blood-collection tubes may be contaminated with endotoxin (315 ± 95 pg/tube) and could therefore be unsuitable for blood collection for endotoxin measurement. Plasma separation and storage are a potential source of contamination. To avoid contamination and error, we have developed new bloodcollection tubes that contain hepann free of endotoxin (LPS) and a gel to separate plasma and blood cells. blood-collection tubes may be contaminated with endotoxin, plasma separation and storage may generate contamination, and blood-collection tubes may adsorb endotoxin to the tube walls.
available blood-collection tubes may be contaminated with endotoxin (315 ± 95 pg/tube) and could therefore be unsuitable for blood collection for endotoxin measurement. Plasma separation and storage are a potential source of contamination. To avoid contamination and error, we have developed new bloodcollection tubes that contain hepann free of endotoxin (LPS) and a gel to separate plasma and blood cells. The LPS content is <4 pg/tube. Samples can be stored and frozen without plasma withdrawal to preclude contamination. LPS recovery experiments have shown that the new blood-collection tubes do not bind LPS to the separation gel or vial wall. With these tubes, in vitro formation of tumor necrosis factor (404 ± 163 ng/L in standard tubes vs <40 ng/L in special collection tubes) is minimized. Greiner), and froze them (at -20 #{176}C). The remaining plasma was kept with the (gel-separated) blood cells in the special tubes and stored frozen. For endotoxin measurements, we pretreated plasma samples by diluting10-fold with pyrogen-free water and heating (5 mm at 75#{176}C) (9).
To study cytokine release, we incubated whole-blood samples in the blood-collection tubes for 2 h at 37#{176}C and then centrifuged them. Each plasma was stored at -20 #{176}C (in Kryo-Vials). TNF was analyzed by an immunoassay (10).
Results
Standard 10-mL blood-collection tubes filled with pyrogen-free water were found to contain about 315 (SD 95) pg of LPS per tube.
Specialpyrogen-free vials(4 mL), which were ifiled with separation gel and 120 jut, units of heparin in a commercial production line, were taken without conscious bias from three different batches and analyzed for endotoxin content. They were found to be almost endotoxin-free (71 of 75 contained <1.5 pg/tube, and 75 of 75 contained 4 pg/tube). No batch-to-batch variation was found.
To study whether the separation gel or the tube wall could represent a source of endotoxin adsorption, we performed recovery experiments in which the collection tubes were filled with an endotoxin standard (65 ngfL of water). Samples were then incubated for 1 h at 37 #{176}C with continuous agitation and analyzed immediately thereafter.
Ten samples contained LPS at 64.5 (SD 5.5) ngfL, indicating that no binding of endotoxin by the gel is present. We also tested the effect of storage on blood samples by not removing the plasma from the bloodcollection tubes before storage. There was no difference in LPS content recovered between plasma removed from the collection tubes before storage [115% (SD 22%), n = 6] and plasma frozen in the special collection tubes [122% (SD 14%), n = 6]. Cytokine analysis revealed that plasma from blood-collection tubes with confirmed endotoxin contamination contained greater concentrations of TNF [404 (SD 163) ng/L, n = 10] than did those incubated in our pyrogen-free tubes (<40 ngfL, n = 9).
DiscussIon
To avoid potential sources of error in the determination of plasma concentrations of endotoxin (or TNF), we have tried to optimize conditions of blood collection and storage. One of the obvious errors is contamination of the blood-collection tubes, as previously shown (5). We selected a heparin preparation shown to be "LPS-free" (judged by the sensitivity of our LPS assay to be <0.75 ngIL) and carefully prepared blood-collection tubes at a standard tube production line. These blood-collection tubes were found to be pyrogen-free or to have borderline endotoxin content.
To avoid other potential sources of contamination, we propose to use vials with a special cell/plasma separation.
The minimized endotoxin contamination of the bloodcollection tubes also reduces potential cytokine generation in vitro (6), which, despite incubation at 37#{176}C for 2 h, was below the detection limit of one TNF assay (<40 ng/L). We also use these tubes for in vitro whole-blood generation of cytokines after LPS stimulation (10-100 pg/L), similar to a previously described system (11).
Use of these blood-collection tubes with a sensitive limulus assay permits the study of patients (e.g., with septic disorders) while avoiding pitfalls in blood sampling and storage.
Note added in proof:
The new blood-collection vials are now available commercially as KabiTube ET#{174} from Chromogenix (formerly Kabi), M#{246}lndal, Sweden.
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